Cardiovascular Diseases Clinical Trial
Official title:
Chronic and Acute Effect of Smoking on the Left and Right Ventricular Systolic and Diastolic Function in Young Healthy Smokers
Impairment of relaxation, the early phase of ventricular diastole is the first stage of
heart diastolic dysfunction. Left ventricular diastolic function can be determined
noninvasively by Echo- Doppler – derived mitral valve flow velocities. The addition of
pulmonary venous flow pattern enables more accurate assessment of left ventricle diastolic
function. The role of the right ventricle in haemodynamic function of the heart is now
emphasized. The right ventricle diastolic function can be assess by recording the Doppler
tricuspid valve flow pattern. Impaired LV diastolic function usually precedes systolic
dysfunction and may cause clinical signs of congestive heart failure. Cigarette smoking is
one of the major risk factors for cardiovascular diseases. The aim of the study was to
assess left and right ventricular diastolic function in healthy, young and slim smokers
before and after smoking one cigarette.
Echocardiographic examination: before and after smoking one cigarette Echocardiographic
evaluation of mitral valve flow, pulmonary venous flow, tricuspid valve flow and hepatic
vein flow to assess diastolic function of ventricles.
Echocardiographic examination: in left lateral position after 10 minutes rest. The first
examination: after a 2-hour non-smoking period, the second: immediately after smoking one
cigarette containing 0.9 mg of nicotine. The duration of the second examination: no more
than 15 minutes.
Echocardiography equipment: Hewlett-Packard SONOS 2000 (Andover, Massachusetts) imaging
system. The transducer’s frequency: 2 MHz.
From the apical four chamber view the visualisation of transmitral flow, pulmonary venous
flow and transtricuspid flow. From subcostal view the visualisation of right superior
hepatic vein and the hepatic vein flow.
;
Observational Model: Defined Population, Time Perspective: Cross-Sectional
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05654272 -
Development of CIRC Technologies
|
||
| Recruiting |
NCT05650307 -
CV Imaging of Metabolic Interventions
|
||
| Recruiting |
NCT04515303 -
Digital Intervention Participation in DASH
|
||
| Completed |
NCT04056208 -
Pistachios Blood Sugar Control, Heart and Gut Health
|
Phase 2 | |
| Recruiting |
NCT04417387 -
The Genetics and Vascular Health Check Study (GENVASC) Aims to Help Determine Whether Gathering Genetic Information Can Improve the Prediction of Risk of Coronary Artery Disease (CAD)
|
||
| Not yet recruiting |
NCT06211361 -
Cardiac Rehabilitation Program in Patients With Cardiovascular Disease
|
N/A | |
| Not yet recruiting |
NCT06032572 -
Evaluation of the Safety and Effectiveness of the VRS100 System in PCI (ESSENCE)
|
N/A | |
| Recruiting |
NCT04514445 -
The BRAVE Study- The Identification of Genetic Variants Associated With Bicuspid Aortic Valve Using a Combination of Case-control and Family-based Approaches.
|
||
| Enrolling by invitation |
NCT04253054 -
Chinese Multi-provincial Cohort Study-Beijing Project
|
||
| Completed |
NCT03273972 -
INvestigating the Lowest Threshold of Vascular bENefits From LDL Lowering With a PCSK9 InhibiTor in healthY Volunteers
|
N/A | |
| Completed |
NCT03680638 -
The Effect of Antioxidants on Skin Blood Flow During Local Heating
|
Phase 1 | |
| Recruiting |
NCT04843891 -
Evaluation of PET Probe [64]Cu-Macrin in Cardiovascular Disease, Cancer and Sarcoidosis.
|
Phase 1 | |
| Completed |
NCT04083872 -
Clinical Study to Investigate the Pharmacokinetic Profiles and Safety of Highdose CKD-385 in Healthy Volunteers(Fasting)
|
Phase 1 | |
| Completed |
NCT04083846 -
Clinical Study to Investigate the Pharmacokinetic Profiles and Safety of High-dose CKD-385 in Healthy Volunteers(Fed)
|
Phase 1 | |
| Completed |
NCT03693365 -
Fluid Responsiveness Tested by the Effective Pulmonary Blood Flow During a Positive End-expiratory Trial
|
||
| Completed |
NCT03619148 -
The Incidence of Respiratory Symptoms Associated With the Use of HFNO
|
N/A | |
| Completed |
NCT03466333 -
Postnatal Enalapril to Improve Cardiovascular fUnction Following Preterm Pre-eclampsia
|
Phase 2 | |
| Completed |
NCT04082585 -
Total Health Improvement Program Research Project
|
||
| Completed |
NCT05132998 -
Impact of a Comprehensive Cardiac Rehabilitation Program Framework Among High Cardiovascular Risk Cancer Survivors
|
N/A | |
| Completed |
NCT05067114 -
Solutions for Atrial Fibrillation Edvocacy (SAFE)
|